Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 12 2 2019
medline: 23 2 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

The global patterns and distribution of case-fatality rates (CFRs) in pediatric severe sepsis and septic shock remain poorly described. We performed a systematic review and meta-analysis of studies of children with severe sepsis and septic shock to elucidate the patterns of CFRs in developing and developed countries over time. We also described factors associated with CFRs. We searched PubMed, Web of Science, Excerpta Medica database, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Cochrane Central systematically for randomized clinical trials and prospective observational studies from earliest publication until January 2017, using the keywords "pediatric," "sepsis," "septic shock," and "mortality." Studies involving children with severe sepsis and septic shock that reported CFRs were included. Retrospective studies and studies including only neonates were excluded. We conducted our systematic review and meta-analysis in close accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Pooled case-fatality estimates were obtained using random-effects meta-analysis. The associations of study period, study design, sepsis severity, age, and continents in which studies occurred were assessed with meta-regression. Meta-analyses to provide pooled estimates of CFR of pediatric severe sepsis and septic shock over time. Ninety-four studies that included 7561 patients were included. Pooled CFRs were higher in developing countries (31.7% [95% CI, 27.3%-36.4%]) than in developed countries (19.3% [95% CI, 16.4%-22.7%]; P < .001). Meta-analysis of CFRs also showed significant heterogeneity across studies. Continents that include mainly developing countries reported higher CFRs (adjusted odds ratios: Africa, 7.89 [95% CI, 6.02-10.32]; P < .001; Asia, 3.81 [95% CI, 3.60-4.03]; P < .001; South America, 2.91 [95% CI, 2.71-3.12]; P < .001) than North America. Septic shock was associated with higher CFRs than severe sepsis (adjusted odds ratios, 1.47 [95% CI, 1.41-1.54]). Younger age was also a risk factor (adjusted odds ratio, 0.95 [95% CI, 0.94-0.96] per year of increase in age). Earlier study eras were associated with higher CFRs (adjusted odds ratios for 1991-2000, 1.24 [95% CI, 1.13-1.37]; P < .001) compared with 2011 to 2016. Time-trend analysis showed higher CFRs over time in developing countries than developed countries. Despite the declining trend of pediatric severe sepsis and septic shock CFRs, the disparity between developing and developed countries persists. Further characterizations of vulnerable populations and collaborations between developed and developing countries are warranted to reduce the burden of pediatric sepsis globally.

Identifiants

pubmed: 30742207
pii: 2724381
doi: 10.1001/jamapediatrics.2018.4839
pmc: PMC6450287
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-362

Commentaires et corrections

Type : ErratumIn

Références

Arch Dis Child. 1999 Jan;80(1):51-5
pubmed: 10325759
Intensive Care Med. 2017 May;43(5):612-624
pubmed: 28349179
Crit Care Med. 2008 Jan;36(1):296-327
pubmed: 18158437
Acta Cardiol Sin. 2015 Nov;31(6):485-93
pubmed: 27122912
Pediatr Emerg Care. 2010 Sep;26(9):622-5
pubmed: 20805778
Pediatr Crit Care Med. 2008 Jul;9(4):414-7
pubmed: 18843251
Indian J Crit Care Med. 2014 Feb;18(2):70-6
pubmed: 24678148
J Thromb Haemost. 2008 Feb;6(2):268-76
pubmed: 18021301
Pediatr Crit Care Med. 2014 May;15(4):e157-67
pubmed: 24583504
Zhongguo Dang Dai Er Ke Za Zhi. 2014 Feb;16(2):194-7
pubmed: 24568917
Biometrics. 2000 Mar;56(1):279-87
pubmed: 10783807
Rev Assoc Med Bras (1992). 2004 Oct-Dec;50(4):439-43
pubmed: 15666028
J Intensive Care Med. 2019 Jul;34(7):563-571
pubmed: 28460591
Pediatr Emerg Care. 2008 Oct;24(10):647-55
pubmed: 19242131
Pediatr Crit Care Med. 2014 Nov;15(9):e370-8
pubmed: 25230313
Crit Care Med. 1985 Jun;13(6):454-9
pubmed: 3995997
Crit Care Med. 2016 Nov;44(11):2010-2017
pubmed: 27513537
Pediatr Crit Care Med. 2016 Nov;17(11):e502-e512
pubmed: 27673385
J Paediatr Child Health. 1999 Oct;35(5):488-92
pubmed: 10571765
Pediatr Crit Care Med. 2006 May;7(3):200-11
pubmed: 16575354
Crit Care Resusc. 2013 Sep;15(3):198-204
pubmed: 23944206
Intensive Care Med. 2007 Dec;33(12):2158-64
pubmed: 17898994
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Intensive Care Med. 1992;18(4):202-5
pubmed: 1430582
Am J Respir Crit Care Med. 2008 Aug 1;178(3):276-82
pubmed: 18511707
Pediatr Crit Care Med. 2005 May;6(3 Suppl):S3-5
pubmed: 15857554
Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57
pubmed: 25734408
J Clin Endocrinol Metab. 2002 Jul;87(7):3118-24
pubmed: 12107211
Crit Care Med. 1984 Jul;12(7):554-9
pubmed: 6734222
Zhonghua Yi Xue Za Zhi. 2015 Feb 3;95(5):353-8
pubmed: 26168670
Crit Care Med. 2001 Jun;29(6):1239-46
pubmed: 11395613
Pediatr Crit Care Med. 2017 Feb;18(2):143-150
pubmed: 27941423
J Pediatr. 2014 Jan;164(1):72-77.e2
pubmed: 24144393
Crit Care Med. 1998 May;26(5):933-8
pubmed: 9590325
Lancet Respir Med. 2018 Mar;6(3):223-230
pubmed: 29508706
Intensive Care Med. 2004 Apr;30(4):536-55
pubmed: 14997291
J Crit Care. 2016 Jun;33:84-9
pubmed: 26928303
Pediatrics. 1998 Aug;102(2):e19
pubmed: 9685464
Pediatr Crit Care Med. 2012 Sep;13(5):501-8
pubmed: 22460772
Arch Dis Child. 1998 Feb;78(2):155-8
pubmed: 9579159
Mol Med. 2011;17(11-12):1146-56
pubmed: 21738952
Zhonghua Er Ke Za Zhi. 2014 Jun;52(6):438-43
pubmed: 25190164
Pediatr Infect Dis J. 2014 Feb;33(2):152-7
pubmed: 24413407
J Paediatr Child Health. 2004 Apr;40(4):221-6
pubmed: 15009554
Pediatr Infect Dis J. 2008 Jun;27(6):538-43
pubmed: 18458649
Arch Dis Child. 2009 May;94(5):348-53
pubmed: 19131419
Rev Chil Pediatr. 2015 Sep-Oct;86(5):331-6
pubmed: 26320678
Clin Infect Dis. 1999 Apr;28(4):770-7
pubmed: 10825037
Pediatr Crit Care Med. 2006 May;7(3):220-4
pubmed: 16575349
PLoS One. 2016 Jul 28;11(7):e0160093
pubmed: 27467522
MEDICC Rev. 2014 Jul-Oct;16(3-4):47-54
pubmed: 25208120
Open Inflamm J. 2011 Oct 7;4:4-15
pubmed: 23723956
Pediatr Cardiol. 2014 Mar;35(3):463-70
pubmed: 24091885
Crit Care Med. 2000 Jul;28(7):2591-4
pubmed: 10921600
J Infect Dis. 1995 Jan;171(1):229-32
pubmed: 7798670
Pediatrics. 2004 Jan;113(1 Pt 1):7-17
pubmed: 14702440
J Infect Dis. 1992 Apr;165(4):695-701
pubmed: 1552198
Intensive Care Med. 2008 Sep;34(9):1690-7
pubmed: 18500425
Intensive Care Med. 2007 Sep;33(9):1609-13
pubmed: 17541546
Crit Care Med. 2011 Nov;39(11):2511-7
pubmed: 21705885
Intensive Care Med. 2013 Feb;39(2):165-228
pubmed: 23361625
Cytokine. 2013 Nov;64(2):590-6
pubmed: 24051223
Crit Care Med. 2017 Apr;45(4):e426-e432
pubmed: 27635771
Intensive Care Med. 2008 Mar;34(3):511-7
pubmed: 18092150
Crit Care. 2014 Jul 08;18(4):R145
pubmed: 25005517
Shock. 2007 Nov;28(5):518-23
pubmed: 17589380
Medicine (Baltimore). 2016 Aug;95(35):e4651
pubmed: 27583886
Pediatr Crit Care Med. 2005 Jul;6(4):470-2
pubmed: 15982437
JAMA. 1991 Sep 4;266(9):1242-5
pubmed: 1870250
J Pediatr (Rio J). 2012 Sep-Oct;88(5):417-22
pubmed: 23033000
Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):46-53
pubmed: 26657169
Crit Care Med. 2015 Nov;43(11):2292-302
pubmed: 26323041
Pediatr Crit Care Med. 2014 Jan;15(1):e17-26
pubmed: 24196006
Thromb Haemost. 2010 Jun;103(6):1181-7
pubmed: 20390223
Indian J Crit Care Med. 2014 Jul;18(7):437-41
pubmed: 25097356
Indian Pediatr. 2006 Jul;43(7):619-23
pubmed: 16891682
Crit Care. 2011;15(1):R10
pubmed: 21219619
Crit Care Med. 1988 Jan;16(1):27-33
pubmed: 3338278
PLoS One. 2013 Jun 25;8(6):e66698
pubmed: 23825556
Indian J Crit Care Med. 2016 Oct;20(10):561-569
pubmed: 27829710
Indian J Crit Care Med. 2011 Apr;15(2):102-7
pubmed: 21814374
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Infect Immun. 1998 Nov;66(11):5350-6
pubmed: 9784543
Iran J Pediatr. 2015 Feb;25(1):e324
pubmed: 26199699
Am J Respir Crit Care Med. 2013 May 1;187(9):967-76
pubmed: 23471468
Indian J Pediatr. 2011 Jul;78(7):833-7
pubmed: 21290201
Crit Care Med. 2008 Apr;36(4):1297-303
pubmed: 18379258
Crit Care Med. 2014 Mar;42(3):625-31
pubmed: 24201173
Lancet. 2000 Sep 16;356(9234):961-7
pubmed: 11041396
Indian Pediatr. 2005 Mar;42(3):223-31
pubmed: 15817970
Crit Care. 2011;15(1):R44
pubmed: 21276273
Lancet. 2007 Mar 10;369(9564):836-843
pubmed: 17350452
Crit Care Med. 2005 Apr;33(4):855-9
pubmed: 15818116
Crit Care Med. 2000 Aug;28(8):2979-83
pubmed: 10966282
Intensive Care Med. 1995 Mar;21(3):264-5
pubmed: 7790618
Crit Care. 2012 Oct 01;16(5):R174
pubmed: 23025259
Intensive Care Med. 2013 Sep;39(9):1602-9
pubmed: 23812341
PLoS One. 2014 Mar 13;9(3):e92121
pubmed: 24626215
Pediatr Crit Care Med. 2010 Mar;11(2):213-6
pubmed: 19794326
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Zhonghua Er Ke Za Zhi. 2014 Dec;52(12):918-22
pubmed: 25619349
BMC Pediatr. 2013 Mar 28;13:44
pubmed: 23537039
Clin Infect Dis. 1997 Sep;25(3):640-6
pubmed: 9314453
Pediatr Crit Care Med. 2007 Jan;8(1):23-8
pubmed: 17251878

Auteurs

Bobby Tan (B)

Duke-NUS Medical School, Singapore.

Judith Ju-Ming Wong (JJ)

Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore.

Rehena Sultana (R)

Duke-NUS Medical School, Singapore.

Janine Cynthia Jia Wen Koh (JCJW)

Department of Pediatrics, KK Women's and Children's Hospital, Singapore.

Mark Jit (M)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Yee Hui Mok (YH)

Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore.

Jan Hau Lee (JH)

Duke-NUS Medical School, Singapore.
Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH